August 4, 2021
Barita Investments Limited (BIL) has advised that the following Ordinary Resolutions Nos. 1 and 2 relating to an Additional Public Offering of Shares were passed at an Extraordinary General Meeting held on Tuesday, August 3, 2021:
Resolution No. 1
“THAT the Company hereby approves the issue of up to 160,000,000 ordinary shares (in this resolution “New Ordinary Shares”) (or such greater amount as the Directors in their absolute discretion may approve) in either case, as part of the authorised capital currently unissued for the purposes of raising capital for the benefit of the Company, the general public being invited to subscribe for New Ordinary Shares on such terms (including the number of New Ordinary Shares and the price(s) per New Ordinary Share,) such subscriptions to be in each case as the Directors and/or any duly appointed Committee of Directors shall determine, in all such cases on terms and conditions as the Directors may consider expedient in their absolute discretion AND THAT the Directors may, but shall not be obliged to, elect to upsize the number of New Ordinary Shares as may be made available for subscription by no more than 80,000,000 additional New Ordinary Shares in the event that the invitation is oversubscribed. FURTHER that on issue, the New Ordinary Shares shall be converted and/or confirmed to be ordinary stock units, ranking in all respects pari passu with the existing ordinary stock units of the Company.”
Resolution No. 2
Ordinary Resolution “THAT the Directors and the Secretary of the Company do execute all steps and documents and are hereby authorised to execute all steps and documents in order to implement and effectuate the issue of the New Ordinary Shares aforesaid on terms and conditions as the Directors may consider expedient in their absolute discretion.”
Analyst Certification –The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.
Company Disclosure –The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.